概览
Forum: September 25-26
DIA’s 2024 Latin America Annual Meeting offers unparalleled opportunities for networking and knowledge sharing with key stakeholders to advance and implement life sciences R&D initiatives in Latin America and the Caribbean. This year, session tracks on Regulatory/Clinical, Safety and Pharmacovigilance, and Medical Affairs and Scientific Communications (MASC) expand the scope of the meeting, with cross-track sessions facilitating discussions on key connection points across these areas to promote collaboration and synergy within organizations.
Join the conversation on multi-regional cooperation, global harmonization and reliance, lessons learned, and best practices. Don’t miss the chance to be part of this pivotal event, where innovation and cooperation come together to shape the future of healthcare in the region. Engage with experts from ANMAT, ANVISA, ARCSA, COFEPRIS, DIGEMID, DINAVISA, European Medicines Agency, FDA, Ministry of Health of Costa Rica, Ministry of Public Health – Uruguay, South African Health Products Regulatory Authority (SAHPRA), and more!
*The primary language is English, however simultaneous interpretation in Spanish and Portuguese will be available during this meeting.
Need Approval in Order to Attend?
Download and fill out our Justification Letter to demonstrate to your supervisor why this is a must-attend event.
Participant Testimonials
The agenda was prepared including topics of great importance and current affairs. The exchange between the participants is very enriching and gives the possibility of listening first-hand to the experience of prestigious speakers. - Lisette Pérez Ojeda - CECMED, Colombia
It is an important event to share information/experiences, to access the current status and opportunities, to develop ourselves and to implement new strategies/skills/information into the work. – Patricia Dias - LEO Pharma, Brazil
Check out the great content lined up for the Regulatory/Clinical, Safety and Pharmacovigilance, and Medical Affairs and Scientific Communications (MASC) tracks at Latin America Annual Meeting.
Welcome Video in English
Conozca el excelente contenido preparado para las sesiones sobre Regulación/Clínica, Seguridad y Farmacovigilancia, y Asuntos Médicos y Comunicaciones Científicas (MASC) de lo Latin America Annual Meeting.
Confira o ótimo conteúdo preparado para as áreas de Regulamentação/Clínica, Segurança e Farmacovigilância e Assuntos Médicos e Comunicações Científicas (MASC) no Latin America Annual Meeting.
Welcome Video in Spanish/Portuguese
项目委员会
-
Marta Avellar, MBA Medical Information Regional Head, Latin America Canada
Takeda Pharmaceuticals, Brazil -
Arthur Bueno, PharmD, MBA Country Safety Head Back-Up
Sanofi Brazil, Brazil -
Raphael Elmadjian Pareschi, PharmD, MBA Patient Safety Lead/ Head of Pharmacovigilance Brazil
Roche, Brazil -
Flavia Firmino Ribeiro, PharmD Regulatory Policy Lead - Latin America
Eli Lilly and Company, Brazil -
Cammilla Horta Gomes, MA, MPharm Latam Regulatory Policy Lead
Roche, Brazil -
Susan Koepke, MBA Head of Regulatory Affairs LATAM
EMD Serono, Inc., United States -
Lawrence Liberti, PhD, RAC Director, D.K. Kim International Center for Regulatory Science
The Kim Center/ USC DRQS, United States -
Mercedes Paloma Lopez, MA Regional Operations Manager, Latin America
WCG Clinical, United States -
Elkiane Macedo Rama, MSc Associate Director of the 3rd Directorate
Brazilian Health Regulatory Agency (ANVISA), Brazil -
Viktoria Magyar, LLM, MSc Doctoral Student, Department of Regulatory and Quality Sciences
USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences, United States -
Rosana M. Mastellaro, PharmD, RPh Director, Technical Regulatory Affairs and Innovation
Sindusfarma, Brazil -
Barbara Nardi, PharmD Global Director - Medical Communications
Thermo Fisher Scientific, Brazil -
Patricia Oliveira Pereira Tagliari, LLM, MPH Associate Director of the Second Directorate
ANVISA, Brazil -
Lisette Pérez Ojeda Asesora de la Dirección
CECMED, Colombia -
Ana Pineda Zavaleta, MSc International Regulatory Analyst, LAO, OGPS, OPLIA, OC
FDA, United States -
Duglas Rodriguez Calderon, MSc Global Head of LATAM Regulatory Policy, Global Regulatory Policy & Intelligence
Roche, United States -
Maria Antonieta Roman, MPharm Head Regulatory Policy LaCan
Novartis, Mexico -
Diego Alexander Salas, LLM Regulatory Affairs Director
Federación Latinoamericana de la Industria Farmacéutica, A.C., Mexico -
Leonardo Semprun, PharmD Global Regulatory Policy Lead-LatAm
MSD, Panama -
Ricardo Uribe, MBA Region Head, Clinical Network - Latin America
Fortrea Clinical Development Mexico, S. De R.L. de C.V., Mexico -
Gislaine Villarta Capeleti Dib, PharmD Operational Manager
PGA Farma, Brazil -
Susan Zavala Coloma, MS, RPh Specialist, Sanitary Evaluation of Pharmaceutical Products, Biological Products
DIGEMID, Peru -
Representative Invited DIA, Switzerland
